Functional Service Provider (FSP) Model

Building trust and long-term strategic global partnerships

You did an amazing job in such a short time. Thank you very much for your partnership!
Program Lead
Global Pharmaceutical Sponsor

At MMS, our customer-aligned FSP teams go beyond delivery. We partner with you to find the right outsourcing model, level of oversight, scale, and governance to provide a functional sourcing solution that best suits your organization’s unique needs.

Sponsors around the globe engage with MMS as a CRO provider for FSP partnerships in the following areas:

Our FSP models are designed to be flexible and scalable, allowing MMS experts a level of engagement to adapt to your changing needs. Tailored key performance indicators (KPI), governance, and communication plans meet you where you are, as well as provide the tools and structure to achieve your long- and short-term strategic goals.

As an innovative, award-winning CRO, MMS leverages decades of evolving, long-term FSP partnerships with a commitment to process improvement, cost efficiencies, and innovation to help you succeed.

Key benefits of choosing the MMS FSP model include:

  • Experience and consistency of an FSP relationship allows MMS to bring the greatest value and specialized knowledge, rather than other transactional models
  • Effective and efficient communication plans by defining roles and responsibilities, with a clear escalation process
  • Access to global talent ensures seamless resourcing strategies and ability to meet urgent timelines due to regulatory and/or team needs
  • With a focus on innovation and technology, MMS can bring our combined service and technology solutions to build efficient processes and bring time and effort savings
  • Operational efficiencies are gained through interdependent cross-functional services in medical writing, data services, pharmacovigilance, quality control and more
  • Through value-added FSP partnerships, MMS strives for seamless collaborations that build trust

Request more information on our suite of customizable FSP solutions.

Suggested For You

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development

perspectives

October 15th, 2024

Putting the Action in Diversity Action Plans and the Real-Time Data Visualization Technology Needed to Ensure It Happens

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry